Lenvatinib Mesylate

Lenvatinib Mesylate is a multi-target tyrosine kinase inhibitor.
Lenvatinib Mesylate is mainly used to treat some malignant tumors, such as thyroid cancer and renal cell carcinoma.
Lenvatinib Mesylate works by inhibiting the growth and spread of tumor cells. Lenvatinib Mesylate is also used to treat hepatocellular carcinoma and endocrine tumors.
In clinical settings, Lenvatinib Mesylate is usually administered orally. It can be used alone or in combination with other anti-cancer drugs to increase the effectiveness of treatment

It is widely used in the field of cancer treatment.